Clinical trials
7 active trials in Kenya
Recruiting, about to start, or running now.
- A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer NCT05894239
- A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) NCT04961996
- A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) NCT05296798
Top trial sponsors (worldwide)
- AstraZeneca 36 active trials on ClinicalTrials.gov (opens in a new tab)
- Novartis AG 21 active trials on ClinicalTrials.gov (opens in a new tab)
- Roche 18 active trials on ClinicalTrials.gov (opens in a new tab)
- Pfizer Inc. 14 active trials on ClinicalTrials.gov (opens in a new tab)
- Sichuan Baili Pharmaceutical Co., Ltd. 12 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
See every trial on ClinicalTrials.gov (opens in a new tab)
Daiichi Sankyo
Hikma Pharmaceuticals PLC
Fresenius SE & CO
Teva Pharmaceutical
Merck & Co., Inc.